Developer docs
API playgroundTry for free, no card

Search company profiles

AutoCruitment

Full company profile

uuid0002u49

Namestring
AutoCruitment
Legal namestring
AutoCruitment LLC
Company typeenum
Private
Founded yearint
2014
Descriptiontext

AutoCruitment is a privately held clinical trial patient recruitment company headquartered in Raleigh, North Carolina (organized as AutoCruitment LLC, North Carolina jurisdiction), operating as a B2B service provider to pharmaceutical companies, biotechnology firms, contract research organizations (CROs), clinical research sites, and medical device companies. Its core offering is a proprietary web-based direct-to-patient recruitment platform that combines browser-behavior targeting, geotargeting, and AI-assisted EMR data restructuring to identify, pre-qualify, and refer patients to research sites in real time across Phase I-IV pharmaceutical trials, medical device studies, and rescue studies. The platform spans a suite of integrated modules: the AutoCruitment Platform (digital acquisition across 1,500+ channels), sophisticated online I/E-criteria screeners, the AutoCruitment Portal for sponsor/CRO/site visibility and real-time funnel tracking, an EMR Capture & Intelligence module for AI-assisted record processing, a Clinical Phone Screening service, and dedicated project-management/site-engagement teams with documented capability to launch campaigns within three business days.

Revenue is generated through professional-services contracts for patient recruitment, screening, and enrollment services on a study-by-study basis; pricing is not publicly disclosed. Customer segments are horizontal across the clinical-trial value chain, with sponsors (pharma/biotech) and CROs as primary buyers, research sites as users of the portal and as a pass-through distribution layer, and medical-device and decentralized-trial providers as secondary segments. Operational scale reported by the company includes 14,600+ patients enrolled, 700+ clinical trials completed, recruitment operations across 38 countries, and coverage of 120+ therapeutic conditions, with an internally reported average 97% increase in client randomizations. Compliance posture includes GDPR with EU representative and Standard Contractual Clauses, CCPA/CPRA, and Virginia CDPA disclosures, supporting international data flows required for multi-region recruitment campaigns.

The go-to-market motion is enterprise field sales into sponsors and CROs supplemented by a partner model with CROs and a research-site network receiving pre-qualified referrals through the AutoCruitment Portal. The company has been primarily bootstrapped, with only $150,000 in disclosed outside funding (March 2016), and is led by CEO Jill Pellegrino alongside co-founders Bethany Bray, Ben Cooper, and Christopher Klaus, with CFO Eric Setzer and CCO/General Counsel Kathy Twiddy on the management team.

Short descriptiontext

AutoCruitment is a private B2B clinical trial patient recruitment company operating a proprietary direct-to-patient digital platform to target, screen, and refer patients for Phase I-IV trials and rescue studies, serving pharmaceutical, biotech, CRO, research-site, and medical-device clients across 38 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRaleigh, United States
HQ citystring
Raleigh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial recruitment, patient recruitment services, direct-to-patient outreach, EMR data capture, clinical trial enrollment
Industry3 codes
PRIMARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Patient Recruitment
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Patient Recruitment Services
TypeProfessional Services
Description

AutoCruitment provides patient recruitment services to pharmaceutical companies, biotech firms, CROs, research sites, and medical device companies for clinical trials. Revenue is generated through service contracts for patient recruitment, screening, and enrollment services across Phase I-IV clinical trials, medical device trials, and rescue studies.

autocruitment.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

AutoCruitment provides direct-to-patient recruitment services for clinical trials through a proprietary AI-powered platform. The platform restructures EMR data and runs targeted digital advertising campaigns to identify, screen, and refer qualified patients to clinical trial sites for pharmaceutical, biotech, CRO, medical device, and research site sponsors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 97% average increase in randomizations for clients using AutoCruitment services
+4 more records
Product overview1 text field

AutoCruitment offers a unified direct-to-patient clinical trial recruitment platform consisting of the core AutoCruitment Platform, the AutoCruitment Portal for research sites, and supporting service modules including Patient Recruitment Services, Clinical Trial Enrollment Services, EMR Capture & Intelligence, Clinical Phone Screening, and Clinical Trial Recruitment Services for CROs. The platform integrates proprietary targeting technology (browser behavior, geotargeting, 1,500+ digital channels), AI-powered EMR data processing, sophisticated online screening, real-time patient referral via portal, and dedicated project management/site engagement teams to serve pharmaceutical companies, biotech firms, CROs, and research sites across Phase I-IV trials and medical device studies.

Product and service4 records
1AutoCruitment Platform
CategoryRecruitment Technology Platform
2Patient Recruitment Services
CategoryRecruitment Services
3Clinical Trial Enrollment
CategoryEnrollment Services
4EMR Capture & Intelligence
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Clinical Trial Media provides patient recruitment services for clinical trials using digital advertising and outreach, directly comparable in service model and customer base.

TypeDirect peer
Description

Trialbee provides direct-to-patient recruitment, patient engagement, and real-world data services for clinical trials, closely mirroring AutoCruitment's model and customer base across pharma and CROs.

TypeDirect peer
Description

BBK Worldwide is an established patient recruitment and engagement company serving pharmaceutical sponsors and CROs, directly comparable in service offering and therapeutic breadth.

4Deep 6 AI
TypeDirect peer
Description

Deep 6 AI uses AI and EHR data to accelerate clinical trial patient recruitment, directly overlapping with AutoCruitment's AI-powered EMR restructuring and sponsor/CRO customer segments.

TypeDirect peer
Description

SubjectWell recruits patients for clinical trials through direct-to-consumer digital outreach, directly comparable to AutoCruitment's browser behavior and geotargeting recruitment approach.

6Antidote (formerly TrialReach)
TypeDirect peer
Description

Antidote operates a digital patient recruitment platform connecting patients to clinical trials, with a comparable direct-to-patient model and similar sponsor/CRO buyer profile.

TypeBroad incumbent
Description

IQVIA is a global CRO with embedded patient recruitment and site engagement capabilities. As a broad incumbent, it competes with AutoCruitment as part of a much wider services portfolio serving the same pharma sponsors.

TypeOthers
Description

Syneos Health is a full-service biopharmaceutical solutions organization with patient recruitment offerings. As a broad incumbent, it competes with AutoCruitment on bundled vs. standalone recruitment solutions.

TypeEmerging player
Description

Science 37 operates a decentralized clinical trial platform, partially overlapping with AutoCruitment's decentralized trial recruitment support and sharing the same sponsor customer base.

TypeEmerging player
Description

Curebase provides decentralized clinical trial technology including patient recruitment and engagement, representing an emerging competitor in the same digital recruitment space as AutoCruitment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AutoCruitment

Clinical Trial Patient Recruitmentautocruitment.com

AutoCruitment is a private B2B clinical trial patient recruitment company operating a proprietary direct-to-patient digital platform to target, screen, and refer patients for Phase I-IV trials and rescue studies, serving pharmaceutical, biotech, CRO, research-site, and medical-device clients across 38 countries.

What AutoCruitment does

AutoCruitment is a privately held clinical trial patient recruitment company headquartered in Raleigh, North Carolina (organized as AutoCruitment LLC, North Carolina jurisdiction), operating as a B2B service provider to pharmaceutical companies, biotechnology firms, contract research organizations (CROs), clinical research sites, and medical device companies. Its core offering is a proprietary web-based direct-to-patient recruitment platform that combines browser-behavior targeting, geotargeting, and AI-assisted EMR data restructuring to identify, pre-qualify, and refer patients to research sites in real time across Phase I-IV pharmaceutical trials, medical device studies, and rescue studies. The platform spans a suite of integrated modules: the AutoCruitment Platform (digital acquisition across 1,500+ channels), sophisticated online I/E-criteria screeners, the AutoCruitment Portal for sponsor/CRO/site visibility and real-time funnel tracking, an EMR Capture & Intelligence module for AI-assisted record processing, a Clinical Phone Screening service, and dedicated project-management/site-engagement teams with documented capability to launch campaigns within three business days.

Revenue is generated through professional-services contracts for patient recruitment, screening, and enrollment services on a study-by-study basis; pricing is not publicly disclosed. Customer segments are horizontal across the clinical-trial value chain, with sponsors (pharma/biotech) and CROs as primary buyers, research sites as users of the portal and as a pass-through distribution layer, and medical-device and decentralized-trial providers as secondary segments. Operational scale reported by the company includes 14,600+ patients enrolled, 700+ clinical trials completed, recruitment operations across 38 countries, and coverage of 120+ therapeutic conditions, with an internally reported average 97% increase in client randomizations. Compliance posture includes GDPR with EU representative and Standard Contractual Clauses, CCPA/CPRA, and Virginia CDPA disclosures, supporting international data flows required for multi-region recruitment campaigns.

The go-to-market motion is enterprise field sales into sponsors and CROs supplemented by a partner model with CROs and a research-site network receiving pre-qualified referrals through the AutoCruitment Portal. The company has been primarily bootstrapped, with only $150,000 in disclosed outside funding (March 2016), and is led by CEO Jill Pellegrino alongside co-founders Bethany Bray, Ben Cooper, and Christopher Klaus, with CFO Eric Setzer and CCO/General Counsel Kathy Twiddy on the management team.

AutoCruitment firmographics

Firmographics
Name
AutoCruitment
Legal name
AutoCruitment LLC
Website
https://autocruitment.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
AutoCruitment is a private B2B clinical trial patient recruitment company operating a proprietary direct-to-patient digital platform to target, screen, and refer patients for Phase I-IV trials and rescue studies, serving pharmaceutical, biotech, CRO, research-site, and medical-device clients across 38 countries.
Ownership category
akta.pro rank

AutoCruitment industry classification

Industry
Product category
Clinical Trial Patient Recruitment
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Clinical trial recruitment
  • Patient recruitment services
  • Direct-to-patient outreach
  • EMR data capture
  • Clinical trial enrollment

Where AutoCruitment is headquartered

Location

Headquarters

HQ city
Raleigh
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AutoCruitment business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Clinical Trial Patient Recruitment Services: AutoCruitment provides patient recruitment services to pharmaceutical companies, biotech firms, CROs, research sites, and medical device companies for clinical trials. Revenue is generated through service contracts for patient recruitment, screening, and enrollment services across Phase I-IV clinical trials, medical device trials, and rescue studies.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

AutoCruitment product offering

Product offering

Core offering

AutoCruitment provides direct-to-patient recruitment services for clinical trials through a proprietary AI-powered platform. The platform restructures EMR data and runs targeted digital advertising campaigns to identify, screen, and refer qualified patients to clinical trial sites for pharmaceutical, biotech, CRO, medical device, and research site sponsors.

Product overview

AutoCruitment offers a unified direct-to-patient clinical trial recruitment platform consisting of the core AutoCruitment Platform, the AutoCruitment Portal for research sites, and supporting service modules including Patient Recruitment Services, Clinical Trial Enrollment Services, EMR Capture & Intelligence, Clinical Phone Screening, and Clinical Trial Recruitment Services for CROs. The platform integrates proprietary targeting technology (browser behavior, geotargeting, 1,500+ digital channels), AI-powered EMR data processing, sophisticated online screening, real-time patient referral via portal, and dedicated project management/site engagement teams to serve pharmaceutical companies, biotech firms, CROs, and research sites across Phase I-IV trials and medical device studies.

Differentiator

Problem solved

Functional benefit

Products and services

  • AutoCruitment Platform
  • Patient Recruitment Services
  • Clinical Trial Enrollment
  • EMR Capture & Intelligence

Quantifiable outcome

  • 97% average increase in randomizations for clients using AutoCruitment services
  • +4 more outcomes

Companies that use AutoCruitment

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles3 records

AutoCruitment technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

AutoCruitment partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

AutoCruitment competitors and assessment

Company assessment

Direct peers

  • Clinical Trial Media: Clinical Trial Media provides patient recruitment services for clinical trials using digital advertising and outreach, directly comparable in service model and customer base.
  • Trialbee: Trialbee provides direct-to-patient recruitment, patient engagement, and real-world data services for clinical trials, closely mirroring AutoCruitment's model and customer base across pharma and CROs.
  • BBK Worldwide: BBK Worldwide is an established patient recruitment and engagement company serving pharmaceutical sponsors and CROs, directly comparable in service offering and therapeutic breadth.
  • Deep 6 AI: Deep 6 AI uses AI and EHR data to accelerate clinical trial patient recruitment, directly overlapping with AutoCruitment's AI-powered EMR restructuring and sponsor/CRO customer segments.
  • SubjectWell: SubjectWell recruits patients for clinical trials through direct-to-consumer digital outreach, directly comparable to AutoCruitment's browser behavior and geotargeting recruitment approach.
  • Antidote (formerly TrialReach): Antidote operates a digital patient recruitment platform connecting patients to clinical trials, with a comparable direct-to-patient model and similar sponsor/CRO buyer profile.

Broad incumbents

  • IQVIA: IQVIA is a global CRO with embedded patient recruitment and site engagement capabilities. As a broad incumbent, it competes with AutoCruitment as part of a much wider services portfolio serving the same pharma sponsors.

Others

  • Syneos Health: Syneos Health is a full-service biopharmaceutical solutions organization with patient recruitment offerings. As a broad incumbent, it competes with AutoCruitment on bundled vs. standalone recruitment solutions.

Emerging players

  • Science 37: Science 37 operates a decentralized clinical trial platform, partially overlapping with AutoCruitment's decentralized trial recruitment support and sharing the same sponsor customer base.
  • Curebase: Curebase provides decentralized clinical trial technology including patient recruitment and engagement, representing an emerging competitor in the same digital recruitment space as AutoCruitment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

AutoCruitment social profiles

Digital presence

AutoCruitment compliance and trust

Trust signal

Compliance6 records

AutoCruitment financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AutoCruitment leadership team

Management profile

Number of profiles

Profiles6 records

AutoCruitment funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AutoCruitment M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AutoCruitment

What does AutoCruitment do?

AutoCruitment provides direct-to-patient recruitment services for clinical trials through a proprietary AI-powered platform. The platform restructures EMR data and runs targeted digital advertising campaigns to identify, screen, and refer qualified patients to clinical trial sites for pharmaceutical, biotech, CRO, medical device, and research site sponsors.

Is AutoCruitment a public or private company?

AutoCruitment is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AutoCruitment founded?

AutoCruitment was founded in 2014. It employs 51 to 100 people.

Where is AutoCruitment based?

AutoCruitment is headquartered in Raleigh, United States, in the North America region.

How does AutoCruitment make money?

One revenue line is on record: clinical Trial Patient Recruitment Services.

Who are AutoCruitment's main competitors?

Direct peers on record are Clinical Trial Media, Trialbee, BBK Worldwide, Deep 6 AI, SubjectWell and Antidote (formerly TrialReach). IQVIA is listed as a broad incumbent. Syneos Health is listed as an others. Emerging players are Science 37 and Curebase.

Does AutoCruitment have an API?

No public API is recorded for AutoCruitment.

What industry is AutoCruitment in?

AutoCruitment's product category is Clinical Trial Patient Recruitment. Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up). Its NAICS code is 541714 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AutocruitmentPatient Recruitment Company For Clinical TrialsThe article presents a collection of testimonials from clinical trial sites and pharmaceutical sponsors praising AutoCruitment for its patient recruitment services. These endorsements highlight the company's ability to improve enrollment rates, meet study timelines, and provide high-quality referrals across various therapeutic areas. Clients specifically cite transparency, consistent performance, and effective project management as key factors in their continued partnership with the firm.Lincoln International LLCAutoCruitment has been sold to QHP CapitalAutoCruitment has been sold to QHP Capital, with Lincoln International serving as the exclusive financial advisor for the transaction. The deal marks the first sale process for AutoCruitment's founders and aims to support the company's next stage of growth in clinical trial patient recruitment.AutocruitmentUnderstanding Digital Patient RecruitmentAutoCruitment is promoting its digital patient recruitment services for clinical trials, leveraging technologies like direct-to-patient advertising and patient management portals to address industry-wide enrollment challenges. The company highlights that traditional methods often fail to meet targets, costing the industry billions, while digital strategies offer faster, more efficient participant identification and engagement.AutocruitmentPatient Recruitment: How to Accelerate EnrollmentThe article outlines five digital strategies to accelerate patient recruitment in clinical trials, addressing common bottlenecks such as limited reach, complex eligibility, and manual processes. It highlights AutoCruitment as a key partner providing direct-to-patient targeting, automated pre-screening, site engagement teams, and centralized data monitoring. These solutions aim to reduce enrollment timelines by an average of nine months and improve diversity and efficiency in clinical research.AutocruitmentPatient Recruitment Services for Clinical TrialsAutoCruitment offers clinical trial patient recruitment services that utilize advanced digital advertising and data analytics to identify and enroll qualified patients. The company provides a Patient Management Portal for transparency and claims its partners experience a 97% increase in enrollments and save nine months on trial timelines. Their service covers patient populations across more than 35 countries while ensuring compliance with FDA and IRB regulations.AutocruitmentEMR Capture & Intelligence with AutoCruitmentAutoCruitment announced the successful completion of its pilot program for EMR Capture & Intelligence, an AI-powered technology designed to streamline electronic medical record collection for clinical research. The pilot demonstrated a reduction in the EMR collection timeline from two weeks to as little as 16 minutes, with over 90% of potential patients consenting to automated data collection. This development aims to accelerate patient recruitment for life sciences companies by automating consent and screening processes.AutocruitmentClinical Trial Advertising Guidelines You Need for Compliance – AutoCruitmentAn informational guide outlines clinical trial advertising regulations and compliance requirements, covering FDA and EMA oversight, IRB review of recruitment materials, accuracy, patient safety, informed consent, and audience targeting. It recommends clear language, disclosure of investigational status, and IRB approval before distribution. The piece promotes AutoCruitment's compliant patient recruitment services.Venture Capital Access OnlineQHP Capital Acquires AutoCruitmentQHP Capital has acquired AutoCruitment, a company that specializes in digital patient recruitment for clinical research, as of October 27, 2022. This acquisition aims to support AutoCruitment's growth and enhance its capabilities in streamlining the patient recruitment process for clinical trials. QHP Capital's involvement is expected to help AutoCruitment continue innovating in patient recruitment.QhpcapitalQHP Capital Acquires AutoCruitmentQHP Capital, L.P. has acquired AutoCruitment, LLC, a digital patient recruitment platform for clinical trials. The acquisition aims to support AutoCruitment's growth and capability expansion in helping pharmaceutical companies accelerate the commercialization of new treatments.AutocruitmentQHP Capital Acquires AutoCruitment – AutoCruitmentQHP Capital, L.P. announced the acquisition of AutoCruitment, LLC, a digital patient recruitment leader for clinical trials, on October 27, 2022. The strategic financial sponsor aims to support AutoCruitment's continued growth and capability expansion by leveraging its industry network and capital.